Enter the first few characters of Company and click 'Go'
Audited Results of Bafna Pharmaceuticals Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
115.35 |
85.14 |
71.22 |
42.47 |
43.36 |
Manufacturing Expenses |
12.95 |
10.40 |
7.54 |
6.61 |
6.46 |
Personnel Expenses |
15.87 |
14.50 |
11.98 |
10.25 |
9.01 |
Selling Expenses |
0 |
0.14 |
0.01 |
0.01 |
0.01 |
Administrative Expenses |
7.17 |
7.71 |
3.47 |
3.96 |
13.10 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
99.63 |
73.65 |
60.92 |
41.24 |
56.69 |
Operating Profit |
15.72 |
11.49 |
10.30 |
1.23 |
-13.34 |
Other Recurring Income |
3.27 |
2.10 |
0.75 |
0.26 |
0.65 |
Adjusted PBDIT |
18.99 |
13.59 |
11.05 |
1.48 |
-12.68 |
Financial Expenses |
2.04 |
0.79 |
0.74 |
0.10 |
2.13 |
Depreciation |
5.33 |
5.49 |
4.48 |
3.27 |
3.42 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
11.62 |
7.31 |
5.83 |
-1.88 |
-18.23 |
Tax Charges |
0.28 |
0 |
0 |
0 |
1.50 |
Adjusted PAT |
11.34 |
7.31 |
5.83 |
-1.88 |
-19.73 |
Non Recurring Items |
0.15 |
-2.16 |
0 |
-23.33 |
0 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
11.34 |
5.15 |
5.83 |
-25.20 |
-19.73 |
Equity Dividend |
0 |
0 |
0 |
0 |
0 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
-54.48 |
-66.01 |
-71.17 |
-76.99 |
-51.79 |